Aquestive Therapeutics/$AQST
About Aquestive Therapeutics
Ticker
Industry
Employees
AQST Metrics
$278M
-
-$0.44
2.84
-
Price and volume
Market cap
$278M
Beta
2.84
52-week high
$6.23
52-week low
$2.24
Average daily volume
1.6M
Financial strength
Current ratio
6.373
Quick ratio
5.78
Long term debt to equity
-80.057
Total debt to equity
-81.173
Interest coverage (TTM)
-1.33%
Management effectiveness
Return on assets (TTM)
-15.57%
Return on equity (TTM)
47.45%
Valuation
Price to revenue (TTM)
4.181
Price to book
-6.12
Price to tangible book (TTM)
-6.12
Price to free cash flow (TTM)
-7.164
Growth
Revenue change (TTM)
22.56%
Earnings per share change (TTM)
109.16%
3-year revenue growth (CAGR)
7.89%
3-year earnings per share growth (CAGR)
-36.31%
What the Analysts think about AQST
Analyst Ratings
AQST Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
AQST Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
AQST News
FAQs
What’s the current market cap for Aquestive Therapeutics stock?
What is the P/E ratio for Aquestive Therapeutics stock?
Does Aquestive Therapeutics stock pay dividends?
No, Aquestive Therapeutics (AQST) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Aquestive Therapeutics dividend payment date?
Aquestive Therapeutics (AQST) stock does not pay dividends to its shareholders.
What is the beta indicator for Aquestive Therapeutics?
Aquestive Therapeutics (AQST) has a beta rating of 2.84. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.